Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending October 18, 2015
Vitamin D-related Factors in MS, Studying the effects in Denmark
Brain Atrophy in MS, Observing changes over time
Total Sodium Concentration in MS Brains, Does it indicate severity?
Natalizumab in RRMS, Researching lymphocytosis as an efficacy biomarker
Depression in MS, Correlating differences with limbic system functions
Must reads for theWeek ending October 11, 2015
Pixantrone in Active Multiple Sclerosis, After immunomodulatory therapy fails
SNPs Associated With Interferon Beta Response, Which may have predictive value?
BMI and Interferon Beta Response, Associating mass with disease status
Vitamin D and Immunomodulatory Therapies, Studying effects on inflammation markers
Progranulin Genetic Polymorphisms and Disease Course, What influence do they exert?
Must reads for theWeek ending October 4, 2015
2D:4D Ratio as Predictor of MS Status, Assessing the associations
MS Lesion Formation, Weekly MRIs show their evolution
Smoking Cessation in Prevalent MS, How does it affect prognosis?
Interferon Therapy in SPMS, Analyzing its efficacy
Disability Progression in MS, Is response to cytomegalovirus a positive factor?
Must reads for theWeek ending September 27, 2015
Neurogranin Levels as Alzheimer Biomarker, Does elevation signal cognitive decline?
Guideline on Status Epilepticus, ILAE revises concepts, definition, and classification
Progression to Dementia in Parkinson Disease, Uncovering predictors of decline
Serum Sphingolipid Panels in Migraine, Do they have predictive value?
Sleep and the Common Cold, Associating duration with susceptibility
Must reads for theWeek ending September 20, 2015
CNS Tissue Destruction in MS, Novel MRI scale measures extent of damage
Breastfeeding in Relapsing-Remitting MS, Does it increase relapse risk?
Assessing Balance Impairment, Correlating inertial sensors with standard scales
MS and Tremor in US Dentists, Does mercury exposure increase risks?
Predicting Disability in Relapse Onset MS, Associating motor network efficiency with EDDS score